Travel-screening documentation to enable the "Identify-Isolate-Inform" framework for emerging infectious diseases: It's all in the details

• Published in: Infection control and hospital epidemiology Vol. 41; no. 12; pp. 1449 - 1451
• Main Authors: Sánchez, Sarimer M, Searle, Eileen F, Rubins, David, Dutta, Sayon, Ware, Winston, Biddinger, Paul D, Shenoy, Erica S
• Format: Journal Article
• Language: English
• Published: United States Cambridge University Press 01-12-2020
• Subjects: Communicable Disease Control - methods; Communicable Disease Control - organization & administration; Communicable Diseases, Emerging - epidemiology; Communicable Diseases, Emerging - prevention & control; Coronavirus Infections - epidemiology; Coronavirus Infections - prevention & control; Coronaviruses; COVID-19; COVID-19 - epidemiology; COVID-19 - prevention & control; Decision Support Techniques; Documentation; Guideline Adherence - statistics & numerical data; Humans; Infectious diseases; Mass Screening - methods; Massachusetts - epidemiology; Middle East respiratory syndrome; Nursing; Pandemics; Records; Respiratory diseases; Risk Assessment - methods; SARS-CoV-2; Travel - trends; Travel Medicine - methods; Travel Medicine - trends; Travel-Related Illness; Massachusetts; Middle East; United States > US; New York City New York
• ISSN: 0899-823X; 1559-6834
• DOI: 10.1017/ice.2020.338

The early phase of the coronavirus disease 2019 (COVID-19) pandemic and ongoing efforts for mitigation underscore the importance of universal travel and symptom screening. We analyzed adherence to documentation of travel and symptom screening through a travel navigator tool with clinical decision support to identify patients at risk for Middle East Respiratory Syndrome.